Search Results 191-200 of 14789 for litzow

  1. Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy - Mayo Clinic

    Mark Litzow, M.D.. Contact information: Cancer Center Clinical Trials Referral Office. 855-776-0015. Closed for enrollment. More information. Publications.

  2. Top cancer research stories of 2024 - Mayo Clinic News Network

    "These results are encouraging and establish a new standard of treatment for people with BCP-ALL," says Mark Litzow, M.D., lead study author and a Mayo ...

  3. Publications - Timothy S. Larson, M.D. - Mayo Clinic

    ... Litzow MR, Cosio FG, Larson TS, Gertz MA, Stegall MD. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) ...

  4. Publications - Taimur Sher, M.B.B.S., M.D. - Mayo Clinic

    Singh A, Al-Kali A, Begna KH, Litzow MR, Larsen JT, Sher T, Abdelmagid MG, Farrukh F, Reichard KK, Gangat N, Pardanani A, Tefferi A. Midostaurin therapy for ...

  5. Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients with Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

    Mark Litzow, M.D.. Contact information: Cancer Center Clinical Trials Referral Office. (855) 776-0015. Closed for enrollment. Jacksonville, Fla. Mayo Clinic ...

  6. Publications - David J. Schembri Wismayer, M.D. - Mayo Clinic

    2008; 20(3):39-43. Litzow MR, Repoussis PD, Schroeder G, Schembri-Wismayer D, Batts KP, Anderson PM, Arndt CA, Chen MG, Gastineau DA, Gertz MA, Inwards DJ ...

  7. Publications - Vivek N. Iyer, M.D., M.P.H. - Mayo Clinic

    ... Litzow MR, Hashmi SK, Yadav H, Iyer VN, Scott JP, Wylam ME, Cartin-Ceba R, Patnaik MM. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell ...

  8. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301) - Mayo Clinic

    Mark Litzow, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Cancer- ...

  9. A Study of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with MCL-1 Dependence ≥ 40% - Mayo Clinic

    Mark Litzow, M.D.. Contact information: Cancer Center Clinical Trials Referral Office. (855) 776-0015. Closed for enrollment. Jacksonville, Fla. Mayo Clinic ...

  10. Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation - Mayo Clinic

    Mark Litzow, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...